Use of cardiac magnetic resonance to detect changes in metabolism in heart failure
Author(s) -
W. D. Watson,
Jack J. Miller,
Andrew Lewis,
Stefan Neubauer,
Damian J. Tyler,
Oliver J. Rider,
Ladislav Valkovič
Publication year - 2020
Publication title -
cardiovascular diagnosis and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.83
H-Index - 22
eISSN - 2223-3660
pISSN - 2223-3652
DOI - 10.21037/cdt.2019.12.13
Subject(s) - phosphocreatine , adenosine triphosphate , medicine , heart failure , nuclear magnetic resonance spectroscopy , metabolism , energy metabolism , spectroscopy , biochemistry , nuclear magnetic resonance , cardiology , chemistry , physics , quantum mechanics
The heart has a massive adenosine triphosphate (ATP) requirement, produced from the oxidation of metabolic substrates such as fat and glucose. Magnetic resonance spectroscopy offers a unique opportunity to probe this biochemistry: 31 Phosphorus spectroscopy can demonstrate the production of ATP and quantify levels of the transport molecule phosphocreatine while 13Carbon spectroscopy can demonstrate the metabolic fates of glucose in real time. These techniques allow the metabolic deficits in heart failure to be interrogated and can be a potential future clinical tool.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom